Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 10 of 10

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Reduction of choroidal thickness was not associated with the outcomes of photodynamic therapy for pachychoroid spectrum diseases

norihiko misawa; akika kyo; kumiko hirayama; Manabu Yamamoto; michiko hirabayashi; Takeya Kohno; shigeru honda

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):294.

ARVO Annual Meeting Abstract June 2017

5-year outcome of initial treatment with ranibizumab monotherapy for polypoidal choroidal vasculopathy with good visual acuity

Takeya Kohno; Manabu Yamamoto; Tomoko Tamachi; Jyunji Asai; Natsuko Oishi; Shinsuke Ataka; Ayako Yasui; Akira Cho; Michiko Hirabayashi; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):880.

ARVO Annual Meeting Abstract June 2017

One year outcome of treat and extend regimen of aflibercept for polypoidal choroidal vasculopathy

Tomoko Tamachi; Takeya Kohno; Akika Kyo; Manabu Yamamoto; Natsuko Oishi; Jyunji Asai; Shinsuke Ataka; Ayako Yasui; Akira Cho; Michiko Hirabayashi; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):885.

ARVO Annual Meeting Abstract September 2016

2-year results of switching to aflibercept for polypoidal choroidal vasculopathy in patients refractory to ranibizumab

Takeya Kohno; Manabu Yamamoto; Akira Cho; Kumiko Hirayama; Ayako Yasui; Shinsuke Ataka; Michiko Hirabayashi; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):514.

ARVO Annual Meeting Abstract June 2015

Changes of Fundus Autofluorescence after Reduced Fluence Photodaynamic Therapy with Verteporfin in Patients with Central Serous Choroiretinopahty

Takeya Kohno; Manabu Yamamoto; Kumiko Yoshimoto; Akira Cho; Shogo Ogawa; Michiko Hirabayashi; Tomohiro Ikeda; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3729.

ARVO Annual Meeting Abstract April 2014

Six-month results of switching to aflibercept for polypoidal choroidal vasculopathy in patients refractory to ranibizumab

Takeya Kohno; Manabu Yamamoto; Akira Cho; Yusaku Yoshida; Hisashi Iwami; Yuta Sawa; Kumiko Yoshimoto; Michiko Hirabayashi; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3839.

ARVO Annual Meeting Abstract June 2013

Visual acuity loss at a two-year follow-up in patients with exudative age-related macular degeneration treated with ranibizumab and as needed retreatment basis

Takeya Kohno; Manabu Yamamoto; tasuku yoneda; Yusaku Yoshida; Hisashi Iwami; Mayumi Kaida; Michiko Hirabayashi; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3795.

ARVO Annual Meeting Abstract March 2012

Fundus Autofluoresence and Spectral Domain OCT Findings at the Junction between the Altered and Normal Chorioretina in Patients with Tilted Disc Syndrome

Takeya Kohno; Manabu Yamamoto; Hisashi Iwami; Mayumi Kaida; Yuusaku Yoshida; Tasuku Yoneda; Michiko Hirabayashi; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1153.

ARVO Annual Meeting Abstract March 2012

The Treatment Of Chronic Central Serous Chorioretinopathy With Reduced Power Pdt

Mayumi Kaida; Takeya Kohno; Michiko Hirabayashi; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5399.

ARVO Annual Meeting Abstract April 2011

Spectral Domain OCT Findings in Patients with Polypidal Choroidal Vasculopathy

Takeya Kohno; Manabu Yamamoto; Hisashi Iwami; Shinsuke Ataka; Mayumi Kaida; Michiko Hirabayashi; Kunihiko Shiraki

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2200.

Advertisement